Drug intelligence / Profile preview

dosmalfate

Development stage
Unknown
Lead developer
Faes Farma
Modality
Small Molecules
Administration
Oral
01

Overview

Dosmalfate is a cytoprotective and anti-ulcer agent consisting of a complex of the flavonoid diosmin and aluminum octasulfate. It is primarily indicated for the treatment of gastric and duodenal ulcers, as well as acute and chronic gastritis. Similar in mechanism to sucralfate, dosmalfate acts locally by forming a protective polyanionic barrier over ulcerated or inflamed gastric mucosa, which shields the tissue from aggressive factors such as gastric acid, pepsin, and bile salts. The inclusion of diosmin provides additional therapeutic benefits through its anti-inflammatory and antioxidant properties, which promote mucosal healing and reduce oxidative stress in the gastric lining. Originally developed by FAES Farma, the drug is manufactured and marketed as a generic or established product by various companies, including Guangzhou Welman Pharmaceutical in China.

Brand names
Diotul
Other names
diosmin aluminum octasulfate
02

Targets

PEP (Pepsin)

Beyond the preview

Go deeper on dosmalfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dosmalfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call